Purification and characterisation of the breast cancer metastasis suppressor, BRMS1

Protein Expression and Purification

Volumn 67, Issue 2, 2009, Pages 70-75

  Smith, Joanne ^a   Naseem, Riffat ^b   Webb, Michelle ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antibodies; BRMS1; Hsp27; Metastasis

Indexed keywords

BRMS1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 27; RECOMBINANT PROTEIN; TUMOR PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BREAST TUMOR; CHEMISTRY; CIRCULAR DICHROISM; ESCHERICHIA COLI; FEMALE; GENETICS; HUMAN; IMMUNOPRECIPITATION; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; METASTASIS; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; PROTEIN FOLDING; RABBIT; SOLUBILITY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; CIRCULAR DICHROISM; ESCHERICHIA COLI; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN FOLDING; RABBITS; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 67650177061     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.04.010     Document Type: Article

References (16)

1. Seraj M.J., Samant R.S., Verderame M.F., and Welch D.R. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 60 (2000) 2764-2769
2. Samant R.S., Debies M.T., Shevde L.A., Verderame M.F., and Welch D.R. Identification and characterization of murine ortholog (Brms1) of breast cancer metastasis suppressor 1 (BRMS1). Int. J. Cancer 97 (2002) 15-20
3. Samant R.S., Seraj M.J., Saunders M.M., Sakamaki T.S., Shevde L.A., Harms J.F., Leonard T.O., Goldberg S.F., Budgeon L., Meehan W.J., Winter C.R., Christensen N.D., Verderame M.F., Donahue H.J., and Welch D.R. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 18 (2001) 683-693
4. Meehan W.J., Samant R.S., Hopper J.E., Carrozza M.J., Shevde L.A., Workman J.L., Eckert K.A., Verderame M.F., and Welch D.R. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 279 (2004) 1562-1569
5. Liu Y., Smith P.W., and Jones D.R. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell. Biol. 26 (2006) 8683-8696
6. Provencher S.W., and Glockner J. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20 (1981) 33-37
7. Hurst D.R., Mehta A., Moore B.P., Phadke P.A., Meehan W.J., Accavitti M.A., Shevde L.A., Hopper J.E., Xie Y., Welch D.R., and Samant R.S. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem. Biophys. Res. Commun. 348 (2006) 1429-1435
8. Garrido C., Brunet M., Didelot C., Zermati Y., Schmitt E., and Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5 (2006) 2592-2601
9. Aldrian S., Trautinger F., Fröhlich I., Berger W., Micksche M., and Kindas-Mügge I. Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 7 (2002) 177-185
10. Lemieux P., Harvey J., Guise T., Dallas M., Oesterreich S., Yin J., Selander K., and Fuqua S. Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo. J. Bone Miner. Res. 14 (1999) 1570-1575
11. Shevde L.A., Samant R.S., Goldberg S.F., Sikaneta T., Alessandrini A., Donahue H.J., Mauger D.T., and Welch D.R. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp. Cell Res. 273 (2006) 229-239
12. Cicek M., Fukuyama R., Welch D.R., Sizemore N., and Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res. 65 (2005) 3586-3595
13. Samant R.S., Clark D.W., Fillmore R.A., Cicek M., Metge B.J., Chandramouli K.H., Chambers A.F., Casey G., Welch D.R., and Shevde L.A. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol. Cancer 16 (2007) 6
14. Luo J., Kamata H., and Karin M. IKK/NF-κB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115 (2005) 2625-2632
15. Guerrini L., Casalino L., Corti A., and Blasi F. NF-kappa B-mediated regulation of urokinase gene expression by PMA and TNF-alpha in human A549 cells. FEBS Lett. 393 (1996) 69-73
16. Park K.J., Gaynor R.B., and Kwak Y.T. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J. Biol. Chem. 278 (2003) 35272-35278